DJIA 18,080.14 21.45 0.12%
NASDAQ 5,092.09 36.02 0.71%
S&P 500 2,117.69 4.76 0.23%
market minute promo

Alnylam Pharmaceuticals (NASDAQ: ALNY)

119.01 0.29 (0.24%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ALNY $119.01 0.24%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $118.04
Previous Close $118.72
Daily Range $116.81 - $120.28
52-Week Range $47.03 - $132.99
Market Cap $10.0B
P/E Ratio -24.48
Dividend (Yield) $0.00 (0.0%)
Volume 322,919
Average Daily Volume 724,144
Current FY EPS -$2.90

Sector

Healthcare

Industry

Drug Makers

Alnylam Pharmaceuticals (ALNY) Description

A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes. Website: http://www.alnylam.com/

News & Commentary

Why Alnylam Pharmaceuticals, Inc. Shares Are Soaring Today

Alnylam Pharmaceuticals, Inc. has reported positive phase 2 results for patisiran.

InsiderInsights.com Daily Round Up 4/23/15: GE, OMN, COCP, AGCO

The Zacks Analyst Blog Highlights: Amgen, Medicines, Athersys and Alnylam - Press Releases

Use Options For a Chance To Buy ALNY at a 32% Discount

Alnylam Strengthens Its Clinical Case Once Again

Alnylam Reports Positive Patisiran Results, Shares Up - Analyst Blog

Biotech Stock Roundup: Amgen Starts Earnings Season on Strong Note, Setbacks for Ampio & Athersys -

Biotech Stock Roundup: Amgen Starts Earnings Season on Strong Note, Setbacks for Ampio & Athersys - Analyst Blog

Morning Market Gainers

Benzinga's Top #PreMarket Gainers

CAR-T Therapy Stocks Hit Hard Following AACR Data

See More ALNY News...

ALNY's Top Competitors

ALNY $119.01 (0.24%)
Current stock: ALNY
AMGN $167.91 (-0.74%)
Current stock: AMGN
GILD $103.70 (-1.44%)
Current stock: GILD
BIIB $401.71 (-6.64%)
Current stock: BIIB